Related by context. All words. (Click for frequent words.) 80 Prolongs Survival 80 Phase 2b Clinical Trial 79 Advanced Melanoma 79 Meets Primary Endpoint 78 Previously Treated 78 Clinical Trial Results 78 Preclinical Data 78 Improves Survival 78 Shows Efficacy 77 Psoriasis Drug 77 Demonstrates Sustained 77 Drug Shows Promise 77 Lupus Drug 77 Phase 2b Trial 77 Demonstrates Significant 77 Investigational Drug 76 Phase IIb Clinical Trial 76 Improves Outcomes 76 Chronic Hepatitis C 76 Rheumatoid Arthritis Patients 76 Multiple Myeloma Patients 76 Drug Candidate 76 Initiates Clinical Trial 76 Vaccine Adjuvant 76 Lung Cancer Drug 76 Treatment Naive Patients 76 Shows Promise Against 76 Survival Benefit 76 Protease Inhibitor 76 Phase III Clinical Trial 76 Patient Enrollment 76 Antitumor Activity 76 Investigational Treatment 76 Anti Tumor Activity 76 FDA Okays 76 Combo Therapy 76 Treated Patients 76 Adjunctive Therapy 76 Patients Treated With 76 Initiate Phase III 76 Pooled Analysis 76 Completes Patient Enrollment 76 Phase 2a Trial 76 Advanced Prostate Cancer 75 Combination Treatment 75 Submits NDA 75 Demonstrates Efficacy 75 Renal Cancer 75 Improved Survival 75 Single Dose 75 Novel Antibiotic 75 Treatment Reduces 75 Investigational Compound 75 Long Term Efficacy 75 Nicotine Vaccine 75 Anticancer Activity 75 Demonstrated Significant 75 Oral Fingolimod 75 Initiates Clinical 75 Patients Receiving 75 Myeloma Patients 75 Phase IIb Trial 75 Present Preclinical Data 75 Newly Diagnosed Multiple Myeloma 74 RNAi Therapeutic 74 Rotavirus Vaccine 74 Oral Presentations 74 Immunomedics Announces 74 Investigational Agent 74 Phase III Trial 74 Clinical Trial Evaluating 74 Demonstrates Positive 74 Presents Preclinical Data 74 Potent Antiviral Activity 74 Acute Heart Failure 74 Relapsed Refractory 74 Successfully Completes Phase 74 Phase III Trials 74 First Patient Enrolled 74 Dose Escalation 74 Study Evaluates 74 Castration Resistant Prostate Cancer 74 Osteoporosis Treatment 74 Patients Suffering 74 Receives Orphan Drug Designation 74 Prostate Cancer Vaccine 74 Hepatitis C Genotype 74 Presents Positive 74 Severe Sepsis 74 Osteoporosis Drug 74 Treatment Naïve 74 Guidelines Recommend 74 Granted Orphan Drug 74 Epilepsy Drug 74 First Patient Dosed 74 Hsp# Inhibitor 74 Initiates Enrollment 74 Adjuvant Chemotherapy 74 Schizophrenia Drug 74 Antiviral Activity 74 Relapsed Multiple Myeloma 74 Files IND 74 Demonstrates Potent 74 Anti Tumor 74 Infected Patients 74 Gout Drug 74 Randomized Clinical Trials 74 Newly Diagnosed Patients 74 Chronic Hepatitis B 74 Clinical Trial Data 74 Significantly Improved 74 Hospital Acquired Pneumonia 74 Completes Enrollment 74 Therapy Improves 74 JAK2 Inhibitor 74 Hormone Refractory Prostate Cancer 74 Drug Fails 74 Is Well Tolerated 74 Proves Effective 74 Shows Promising 73 Inflammatory Arthritis 73 FDA Approves Drug 73 Metastatic Melanoma 73 Randomized Trials 73 Appears Safe 73 Study Evaluating 73 Adjuvant Treatment 73 Guidelines Issued 73 Treatment Experienced 73 RNAi Therapeutics 73 Hematological Cancers 73 FDA Approvals 73 Postmenopausal Osteoporosis 73 Pharmacyclics Announces 73 Colorectal Cancer Patients 73 Resistant Hypertension 73 Kidney Transplant Patients 73 Initiates Phase III 73 Phase 1b Clinical Trial 73 FDA Accepts 73 Telik Announces 73 Vaccine Candidate 73 Treating Chronic 73 Anticancer Drug 73 Teva Provides Update 73 Nuvelo Announces 73 Antiviral Drugs 73 Test Detects 73 See CLINICAL PHARMACOLOGY 73 Disease Modifying 73 Inflammatory Disease 73 Novel Compound 73 Poster Presentations 73 Receives Fast Track 73 HDAC Inhibitor 73 Advanced Colorectal Cancer 73 Clostridium difficile Infection 73 Subgroup Analysis 73 Hematological Malignancies 73 Brentuximab Vedotin SGN 73 Treatment Shows Promise 73 Combination REOLYSIN R 72 Rheumatoid Arthritis Drug 72 Experimental Vaccine 72 Migraine Drug 72 Anticancer Drugs 72 Drug Combo 72 Cutaneous T 72 Laryngeal Cancer 72 Complicated Skin 72 Novel Oral 72 Molecular Diagnostic Test 72 Late Breaker 72 Renal Cell Carcinoma 72 Patients Treated 72 Arthritis Drug 72 Vaccine Protects Against 72 Vicriviroc 72 MEK Inhibitor 72 Prostate Cancer Patients 72 Drug Prevents 72 Therapeutic Vaccine 72 Emerging Therapies 72 Phase 2a Clinical Trial 72 Demonstrate Significant 72 Mylan Receives Approval 72 Pivotal Phase III 72 Kidney Transplants 72 Gene Linked 72 NDA Submission 72 Relapsing Multiple Sclerosis 72 Stem Cell Transplants 72 Hormone Receptor Positive 72 Transplant Patients 72 Improve Diagnosis 72 Treating Depression 72 FDA Clears 72 Heart Failure Patients 72 Plaque Psoriasis 72 Intravenous Formulation 72 Systemic Sclerosis 72 Study Showed 72 Pneumococcal Vaccine 72 Protein Linked 72 First Patient Treated 72 Shingles Vaccine 72 Anemia Drug 72 Breast Cancer Recurrence 72 Advanced Pancreatic Cancer 72 Metabolic Disorder 72 Pivotal Study 72 Dose Ranging 72 Oral Laquinimod 72 Bone Metastases 72 R Bortezomib 72 Begins Dosing 72 Renal Anemia 72 Study Shows Promise 72 Newly Diagnosed 72 Reduces Mortality 72 Fast Track Status 72 II Clinical Trial 72 Critically Ill Patients 72 Trial Evaluating 72 Diabetic Foot Ulcer 72 Gastric Cancer 72 Capsules CII 72 Previously Untreated 72 AVI BioPharma Announces 72 Clinical Outcome 72 Slows Progression 72 Receives Approvable Letter 72 Advanced Renal Cell 72 Genes Linked 72 Advanced Ovarian Cancer 72 Upcoming Investor 72 Statin Therapy 71 Diabetic Neuropathy 71 Migraine Treatment 71 Novel Therapeutic 71 Malaria Vaccine 71 Significant Improvement 71 Receives Orphan Drug 71 Novel Inhibitor 71 Autoimmune Disease 71 Cholesterol Drugs 71 Treat Anemia 71 Fungal Infections 71 PRN FDA Approves 71 Cholesterol Drug 71 Hepatitis C Treatment 71 Seasonal Influenza Vaccine 71 Cardiotoxicity 71 Lung Cancer Trial 71 Genes Identified 71 Viral Suppression 71 Treatment Regimen 71 Biomarker Study 71 Combination Therapy 71 NPS Pharmaceuticals Announces 71 Well Tolerated 71 Blood Pressure Drug 71 Prove Effective 71 Antiplatelet Therapy 71 Proven Effective 71 Lung Cancer Survival 71 Peginterferon Alfa 2a 71 Novel Treatments 71 Data Suggest 71 Clinical Efficacy 71 Tuberculosis Vaccine 71 Receives Milestone Payment 71 Cholesterol Lowering Drug 71 Initiates Phase II 71 Showed Significant 71 Venous Thromboembolism 71 Bosutinib 71 Initiate Clinical Trial 71 Tablet Formulation 71 Post Menopausal 71 Cervical Dysplasia 71 JAK Inhibitor 71 Mouse Model 71 Myelodysplastic Syndromes 71 Boosts Survival 71 Metastatic Colorectal Cancer 71 Successfully Treated 71 Spectrum Pharmaceuticals Announces 71 Neoadjuvant Chemotherapy 71 Topline Results 71 Inhaled Liposomal Ciprofloxacin 71 Poniard Pharmaceuticals Announces 71 Lowers Risk 71 Peginterferon 71 Schizophrenia Treatment 71 Generic Versions 71 HER2 Positive Breast Cancer 71 Preterm Labor 71 Slow Progression 71 Randomized Double Blind 71 Antipsychotic Drug 71 IND Filing 71 Stem Cell Treatment 71 Advanced Solid Tumors 71 Hemodialysis Patients 71 Inhaled Insulin 71 AASLD Meeting 71 Osteoarthritis Patients 71 Inflammatory Diseases 71 Maven Semantic 71 Elderly Patients 71 TB Vaccine 71 Confirms Efficacy 71 HER2 Positive 71 Tyrosine Kinase Inhibitor 71 Collaborators Present 71 Sustained Reduction 71 Pivotal Phase 71 Improve Survival 71 Statin Drugs 71 Study Demonstrates 71 Anticoagulant 71 Efficacious 71 Idenix Novartis 71 Therapeutic Antibody 71 Monotherapy 71 Viral Infections 71 Phase Ib Clinical Trial 71 Antipsychotic Medications 71 Double Blind Placebo 71 Atypical Antipsychotics 71 Severe Asthma 70 Pediatric Patients 70 Artery Disease 70 Kinase Inhibitor 70 Ebola Vaccine 70 Randomized Double blind 70 Lupus Nephritis 70 Sapacitabine 70 Naive Patients 70 J.P. Morgan Healthcare 70 Patients Enrolled 70 Anti Clotting Drug 70 Phase III Clinical Trials 70 Initiates Phase 2b 70 Study Shows Benefits 70 Preclinical Study 70 Glufosfamide 70 Mouse Models 70 Vaccine Prevents 70 Pharmacokinetic Study 70 Pneumonia Vaccine 70 Multiple Sclerosis Rheumatoid Arthritis 70 Ridaforolimus 70 Antidepressants Linked 70 Kidney Transplant Recipients 70 Versus Placebo 70 Gastrointestinal Disorders 70 Randomized Controlled Trials 70 Obesity Linked 70 Sangamo BioSciences Announces 70 Transdermal Patch 70 Vaccine Shows Promise 70 Immunotherapeutic 70 Estrogen Therapy 70 Levels Linked 70 Acute Ischemic Stroke 70 Clinical Outcomes 70 Anti CD# Antibody 70 Drug Coated Stents 70 Protease Inhibitors 70 Antibody Drug Conjugate 70 Pulmonary Arterial Hypertension 70 Prolongs Life 70 Epoetin Alfa 70 Orally Active 70 Recurrent Breast Cancer 70 Recombinant Human 70 Lowering Blood Pressure 70 Vildagliptin 70 Pafuramidine 70 Hepatitis C Virus 70 Aethlon Medical Announces 70 Achieves Primary Endpoint 70 Telaprevir VX 70 Localized Prostate Cancer 70 Chronic Myeloid Leukemia 70 Randomized Phase II 70 Prognostic Value 70 Reduced Risk 70 Patient Accrual 70 Chronic Lymphocytic Leukemia 70 Follicular Lymphoma 70 Multicenter Phase 70 Anti Angiogenesis 70 Polymerase Inhibitor 70 Demonstrates Potential 70 Initiates Dosing 70 Expanded Indication 70 Submits Biologics License Application 70 Crofelemer budesonide foam 70 Metastatic Prostate Cancer 70 Tezampanel 70 Minimally Invasive Treatment 70 Study Reinforces 70 Chronic Renal Failure 70 Overactive Bladder 70 Therapeutic Vaccines 70 Reduce Mortality 70 BiTE Antibody 70 Significantly Reduced 70 Meta Analysis 70 Receives Positive Opinion 70 Soft Tissue Sarcoma 70 Survival Rate 70 Synthetic Peptide 70 Preclinical Models 70 Crit Rev 70 Hepatocellular Carcinoma 70 Reduces Risk 70 Smallpox Vaccine 70 MRSA Infections 70 IND Application 70 Partial Onset Seizures 70 Phase 2b Study 70 Significantly Improves 70 Protein Involved 70 Treatment Resistant 70 Vitro Activity 70 Diagnostic Tests 70 Renal Impairment 70 Adjuvant Therapy 70 Renal Function 70 Therapy Shows Promise 70 Resubmission 70 Male Contraceptive 70 Anticancer Agent 70 Peginterferon Alfa 2b 70 Files Investigational 69 Bipolar Depression 69 Commences Phase 69 Heart Transplant Recipients 69 Unfractionated Heparin 69 ANN INTERN MED 69 Mg Usa 69 Develops Novel 69 Small Molecule 69 Secondary Hyperparathyroidism 69 Targeted Therapies 69 Integrase Inhibitor 69 Antitumor 69 CDC Recommends 69 Serious Infections 69 Gentium Announces 69 Pegloticase 69 Cardiovascular Disease Risk 69 Unresectable 69 Phase IIa Clinical Trial 69 Valvular Heart Disease 69 Inhaled Steroids 69 Hypertensive Patients 69 Kidney Function 69 Ovarian Cancer Patients 69 Milestone Payment 69 Left Ventricular Hypertrophy 69 Cervical Cancer Vaccine 69 Patient Outcomes 69 Telbivudine 69 Anthracycline 69 Osteoporosis Drugs 69 Immune Responses 69 Abstract Accepted 69 R lenalidomide 69 Blood Thinner 69 Long Term Outcomes 69 Early Diagnosis 69 Fracture Risk 69 Valopicitabine 69 Newly Diagnosed Breast Cancer 69 Refractory Hodgkin Lymphoma 69 Colorectal Adenomas 69 Chemotherapeutic Agents 69 Anti Infective 69 Dose Ranging Study 69 Diagnostic Criteria 69 NICE Recommends 69 Antibiotic Use 69 Therapeutic Potential 69 Diabetic Patients 69 Antipsychotic Drugs 69 Autologous Stem Cell Transplantation 69 Initiate Phase 69 Cethromycin 69 Significant Reduction 69 Develop Novel 69 Hedgehog Pathway Inhibitor 69 Humanized Anti 69 Improve Outcomes 69 Respiratory Distress 69 Randomized Study 69 Investigational Oral 69 Cardiovascular Outcomes 69 Antiviral Agents 69 Sleep Disturbances 69 Prenatal Screening 69 Antibiotic Treatment 69 Inhaled Nitric Oxide 69 Genes Predict 69 Fewer Side Effects 69 Mimetics 69 STELARA TM 69 Bone Marrow Transplants 69 Nanoemulsion 69 Pharmacokinetics PK 69 Therapeutic Efficacy 69 Oncology Compounds 69 Chemotherapy Improves 69 Influenza Vaccine 69 Helps Smokers Quit 69 Increased Mortality 69 Often Misdiagnosed 69 ST Elevation Myocardial 69 Chemotherapy Regimen 69 Initiates Phase 69 Cell Transplants 69 pralatrexate injection folate analogue 69 Study Proves 69 Muscle Wasting 69 Prognostic Factors 69 Initiates Clinical Trials 69 Submits Supplemental 69 Threshold Pharmaceuticals Announces 69 Cancer Vaccines 69 Long Term Survival 69 Anti Nausea 69 Simulect 69 Respiratory Virus 69 ISTODAX ® 69 Earns Milestone Payment 69 Antiviral Therapy 69 Testosterone Patch 69 Tigecycline 69 Aggressive Prostate Cancer 69 Drug Resistant 69 Virus Linked 69 Carotid Stenting 69 #:#-#,# CrossRef Medline [002] 69 Receives CE Marking 69 Node Positive 69 Improve Patient Outcomes 69 Glatiramer Acetate 69 IIa Clinical Trial 69 Positive Opinion 69 Opioid Use 69 Solid Tumors 69 Therapeutic Competitors Companies 69 Completes Dosing 69 Glycemic Control 69 Atopic Dermatitis 69 Gene Variation 69 Asthma COPD 69 Diamyd Medical Diamyd 69 Hospitalized Patients 69 #-# Full Text 69 Poorly Controlled 69 Lung Cancer Patients 69 Announces Poster Presentations 69 Pregnancy Linked 69 Erectile Dysfunction Drug 69 Biogen Genentech 69 Study Casts Doubt 69 Confirmatory Phase 69 oncolytic virus therapies 69 Metastatic Renal Cell Carcinoma 69 Lipid Lowering 69 Surgical Procedures 69 FDA Approves Novel 69 Prophylactic Treatment 69 Cancer Stem Cells 68 Morbidity Mortality 68 Pandemic Influenza Vaccines 68 EntreMed Presents 68 BARACLUDE ® 68 Vaginal Gel 68 Chronic Sinusitis 68 Biologic Therapy 68 Companion Diagnostic 68 Immunosuppressant 68 Ovarian Cancer Treatment 68 Randomized Phase 68 Disease Progression 68 Generic Version 68 Antifungal 68 Androgen Deprivation Therapy 68 Liver Failure 68 Rigel R# 68 Effectively Treats 68 Weight Loss Drug 68 Renal Cell Cancer 68 Benign Prostatic Hyperplasia 68 Breast Cancer Treatment 68 Neuroendocrine Tumors 68 Clinical Trial Enrollment 68 Vitamin D Linked 68 Prospective Randomized 68 Antigen Specific 68 Cancer Immunotherapy 68 Heartburn Drugs 68 Treat Heart Failure 68 Aeolus Pharmaceuticals Announces 68 Pivotal Trials 68 GATTEX TM 68 J Shoulder Elbow 68 Complete Remission 68 Immune Cells 68 Inflammatory Markers 68 Adverse Event 68 Hematopoietic Stem Cell Transplantation 68 Announces Presentation 68 Non Inferiority 68 Obese Teens 68 Insulin Pen 68 FDA APPROVES 68 Second Pivotal Phase 68 Gets FDA Clearance 68 personalized cellular immunotherapy 68 Tipranavir 68 Presents Positive Preclinical 68 Clinical Evaluation 68 Implantable Device 68 Regimens 68 Interferon Beta 68 Preclinical Efficacy 68 Significantly Reduces 68 Childhood Immunizations 68 Romiplostim 68 Patients Undergoing 68 Therapeutic Antibodies 68 ALN HPN 68 Reveals Positive 68 Announces Tentative Approval 68 ACE Inhibitors 68 Knee Osteoarthritis 68 Anti Inflammatory Drug 68 Live Attenuated 68 VIVUS Qnexa 68 Fecal Incontinence 68 Findings Reveal 68 Solid Malignancies 68 Bleeding Disorder 68 Metabolic Disease 68 Enlarged Prostate 68 Mg Uk 68 Pivotal Trial 68 Hepatitis B Vaccine 68 Maribavir 68 Key Milestones 68 Stereotaxis Announces 68 Gene Variant 68 Fixed Dose 68 Vaccine Adjuvants 68 Premature Infants 68 ASCO GI 68 Malignant Glioma 68 Stent Placement 68 Golimumab 68 DIRECT Trial 68 Faropenem 68 Nucleoside 68 Novel Mechanism 68 Alvine Pharmaceuticals 68 Eculizumab 68 Randomized Clinical Trial 68 Septic Shock 68 Asthma Treatment 68 Hematology Molecular Pathology 68 Largest Database 68 Postmenopausal Women 68 Generic Version Of 68 Ozarelix 68 Low Dose 68 Randomized Controlled 68 Bare Metal Stents 68 INSPIRE Trial Phase III 68 Hythiam Announces 68 Combination Vaccine 68 Statistically Significant 68 Bladder Cancer 68 Regeneron Pharma 68 Multidrug Resistant 68 Bipolar Mania 68 Eur J 68 Liver Toxicity 68 Biopharmaceutical Industry 68 Panic Disorder 68 Non Invasive Treatment 68 Presents Preclinical 68 Projected Release Date 68 Tumor Response 68 Molecular Pathogenesis 68 Asthma Medication 68 Pegylated Interferon 68 Anemia Drugs 68 Brain Atrophy 68 Epilepsy Drugs 68 Patient Treated 68 Nanophase Announces 68 Autoimmune Diseases 68 Cognitive Impairment 68 Pandemic Influenza Vaccine 68 Darbepoetin Alfa 68 Demonstrates Statistically Significant 68 HCV Genotype 68 Synta Announces 68 Belimumab 68 Receive Milestone Payment 68 Boceprevir 68 BARACLUDE R 68 Carboplatin Paclitaxel 68 R MSCRAMM 68 HPV Vaccines 68 Pivotal Phase II 68 Circulating Tumor Cells 68 Flamel Technologies Announces 68 Prostate Biopsy 68 Genes Involved 68 Sustained Efficacy 68 Atypical Antipsychotic 68 Improves Quality 68 Liprotamase 68 Hyperlipidemia 68 Randomized Phase III 68 Vitrasert R 68 Osteoarthritis Pain 68 Topical Treatment 68 Hepatitis C Infection 68 Plus Ribavirin 68 Autoimmune Disorders 68 Retinal Diseases 68 Menopausal Symptoms 68 Medoxomil 68 Radical Prostatectomy 68 Therapeutic Monoclonal Antibodies 67 Shown Effective 67 Drug Formulation 67 Immune Cell 67 J Clin 67 DOR BioPharma Announces 67 Launches Generic Version 67 Invasive Fungal Infections 67 Controlled Trial 67 Aflibercept 67 Milestone Payment From 67 Commonly Prescribed 67 Respiratory Disorders 67 Patent Expirations 67 Inhaled Corticosteroids 67 ST Segment Elevation 67 Healthbeat Report 67 Platelet Inhibition 67 Genetic Tests 67 Viral Load 67 Romidepsin 67 Aztreonam Lysine 67 Anticancer Compound 67 Chemoradiation 67 Oral Calcitonin 67 XPEL Announces 67 Enrolls First 67 Cancer Therapies 67 Arch Neurol 67 Limb Ischemia 67 Fibromyalgia Pain 67 Gastrointestinal Stromal Tumors 67 Blood Pressure Drugs 67 Diabetic Nephropathy 67 Improve Patient Safety 67 Pemphigus Vulgaris 67 Phase III Pivotal 67 Reduces Pain 67 Bazedoxifene 67 Novel Compounds 67 Arch Facial Plast 67 SPRYCEL ® 67 Bone Fractures 67 Cancer Treatments 67 Seasonal Influenza 67 Refractory Angina 67 Depressive Symptoms 67 Medication Adherence 67 Improve Patient 67 Oral Insulin Capsule 67 Lowers Blood Pressure 67 Genetic Predisposition 67 Novel Vaccine 67 Susceptibility Testing 67 Oral Anticoagulants 67 Febuxostat 67 Psoriasis Patients 67 Elagolix 67 Fabry Disease 67 Chronic Bronchitis 67 Amgen Neulasta R 67 Tyrosine Kinase Inhibitors 67 Bone Marrow Cells 67 Tolerability 67 Hepatitis C Patients 67 Human Antibody 67 Receives Complete Response 67 Meningitis Vaccine 67 Commonly Used 67 TO AVOID PREGNANCY WHILE 67 Provide Outsourced 67 Antithrombotic 67 Antiplatelet 67 Cinacalcet 67 BioSante Pharmaceuticals Announces 67 ARIXTRA R 67 Clinical Guideline 67 CYT# potent vascular disrupting 67 Blood Cancers 67 Malignant Melanoma 67 Adjuvanted 67 Nasal Powder 67 Controlled Study 67 Virus Infection 67 Begin Clinical Trials 67 Vaccine Trial 67 VIVUS Announces 67 Systemic Delivery 67 Human Neural Stem 67 Stem Cell Procedure 67 Doripenem 67 Recombinant Protein 67 Placebo Controlled Study 67 Progressive Multifocal Leukoencephalopathy 67 Helps Identify 67 Postdoctoral Position 67 Antibacterials 67 Peripheral Blood 67 Namenda Memantine HCl 67 Zoledronic Acid 67 Etanercept 67 Cognitive Problems 67 MBRX 67 Significant Improvements 67 evaluating tivozanib 67 Announces FDA Clearance 67 Stomach Cancer 67 Bloodstream Infections 67 Beneficial Effects 67 Premenopausal Women 67 Immunogenicity 67 Novel Therapies 67 microRNA Therapeutics 67 Reports Preclinical Data 67 Perifosine KRX 67 Decitabine 67 Whooping Cough Vaccine 67 Oral Insulin 67 Boxed Warnings 67 Hypercholesterolemia 67 Injection Site 67 Ovarian Cancers 67 Breast Tumors 67 Successfully Treats 67 essential thrombocythemia ET 67 Announce License Agreement 67 Placebo Controlled Trial 67 Receives URAC 67 Prostate Tumors 67 Protein Synthesis 67 Prostate Cancer Survival 67 HBeAg + 67 BioSante Pharmaceuticals Reports 67 Stent Thrombosis 67 Taxane 67 Comorbidities 67 Influenza Vaccine Production 67 Senetek PLC Announces 67 Enzo Biochem Reports 67 Contrast Agents 67 Efficacy Results 67 PRTX 67 Diabetic Neuropathic Pain 67 Pre Cancerous 67 #:#-#,# [001] 67 LibiGel ® 67 Taro Receives 67 Cardiac Resynchronization 67 Study Indicates 67 Hematologic Malignancies 67 Double Blind Randomized 67 Therapy Evaluation 67 Myocardial Ischemia 67 Corcept Therapeutics Announces 67 Epratuzumab 67 Elotuzumab 67 Million Milestone Payment 67 FDA Panel Recommends 67 Counter Cholesterol 67 Obese Patients 67 Pandemic Flu Vaccine 67 Improving Patient Safety 67 Helps Predict 67 Barr Receives Approval 67 Heart Stents 67 Cell Transplant 67 Zorbtive TM 67 Kaydon Corporation Announces 67 novel orally inhaled 67 Rotavirus Vaccines 67 alfa 2a 67 Aliskiren 67 Uterine Fibroid Embolization 67 please visit www.abraxane.com 67 Drug Combinations 67 Brain Tumor Patients 67 Drug Maker 67 Abstracts Accepted 67 Liver Metastases 67 Phase 2a Study 67 BioElectronics Announces 67 Mycophenolate Mofetil 67 Dendritic Cells 67 Human Monoclonal Antibody 67 Colorectal Screening 67 TNF Blockers 67 Entry Inhibitor 67 Blood Thinning 67 Colorectal Cancers 67 Collaborators Publish 67 Safinamide 67 Study Validates 67 FDA Clearance 67 Curr Opin 67 SUTENT ® 67 Endometrial Cancer 67 Dasatinib 67 Transdermal Delivery 67 Bone Fracture 67 Acute Pain 67 Genetic Variation 67 Relapsing Remitting Multiple Sclerosis 67 Personalized Immunotherapy 67 Endovascular Treatment 67 Gene Variants 67 Paclitaxel Carboplatin 67 Orthop Surg 67 Chronic Constipation 67 Help Smokers Quit 67 Recurrent Ovarian Cancer 67 Helps Determine 67 bone marrow reticulin deposition 67 Panzem R 67 Total Knee Arthroplasty 67 J Allergy Clin 67 Oral Anticoagulant 67 Ventricular Arrhythmias 67 Oral Cladribine 67 Bucindolol 67 Islet Transplantation 67 Acute Coronary Syndromes 67 Monoclonal Antibody 67 Antibody Discovery 67 Smoking Linked 67 Oncolytic 67 Cognitive Deficits 67 investigational oral inhibitor 67 Invasive Breast Cancer 67 Neurocrine Biosciences Announces 67 Sinus Infections 67 Peginterferon alfa 2b 67 Detect Cancer 67 Ischemic Stroke 67 Nasdaq Deficiency Notice 67 NS5b 66 Prevent Stroke 66 Increases Risk 66 SPL# Gel vaginal microbicide 66 Insulin Glargine 66 Internationally Recognized 66 GeoMet Announces 66 Breast Tumor 66 FDA Approves Generic 66 Symptom Relief 66 Transplant Rejection 66 Carfilzomib 66 Antifungals 66 chronic eosinophilic leukemia 66 Glaucoma Treatment 66 Tissue Engineered 66 Clinically Tested 66 ST PHOTO CAROLINE 66 Antidepressant Drug 66 Announce Collaboration Agreement 66 Antiviral Drug 66 Testosterone Gel 66 Therapy Reduces